This article was originally published in The Gray Sheet
Blood glucose meter gains expanded 510(k) clearance for alternate-site testing using blood from the palm and forearm. The expanded clearance also includes BD's Paradigm Link blood glucose meter, co-developed with Medtronic, and "makes palm testing the equivalent to fingertip testing," according to BD...
You may also be interested in...
BD is preparing for functionality testing of its development-stage Micro Infuser wearable drug-delivery system, incorporating micro-needles to deliver drugs just below the skin's surface to minimize pain
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.